RAC 1.81% $1.63 race oncology ltd

[INTERVIEW] Breaking Barriers in Cancer Treatment: Race Oncology Pioneers a New Era with Bisantrene, page-29

  1. 3,271 Posts.
    lightbulb Created with Sketch. 350
    I'm just looking for opinions on the quality of these interviews.

    They don't seem too good to me.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.